Broadfin Capital

Summary

The company was established in North America in United States. The main department of described VC is located in the New York.

We also calculated 1 valuable employee in our database.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Broadfin Capital, startups are often financed by CMEA Capital, Shmuel Kabili, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Deerfield, Cormorant Asset Management. In the next rounds fund is usually obtained by Yelin Lapidot Investment House, Sectoral Asset Management, Rock Springs Capital.

Among the various public portfolio startups of the fund, we may underline Iovance Biotherapeutics, Advaxis, RedHill Biopharma Among the most successful fund investment fields, there are Health Care, Health Diagnostics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The fund is constantly included in less than 2 deals per year. Deals in the range of 50 - 100 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2014. The important activity for fund was in 2015. Comparing to the other companies, this Broadfin Capital performs on 71 percentage points more the average number of lead investments.